Skip to main content

Table 3 The pooled breast cancer detection rates in different subgroups of population screening programs (China, 2010–2023)

From: Breast cancer screening and early diagnosis in China: a systematic review and meta-analysis on 10.72 million women

Subgroup

Databases

Total

Events

CDRs, ‰ (95% CI)

Residence

Urban

19

2,594,325

4,348

2.28 (1.70–2.94)

Rural

20

10,164,379

6,060

0.70 (0.57–0.83)

Screening age

 < 40

11

682,816

218

0.24 (0.13–0.40)

 

40–49

11

1,385,665

1,081

1.11 (0.85–1.39)

 

50–59

11

947,955

862

1.36 (1.06–1.70)

 

 ≥ 60

9

288,840

258

1.76 (1.03–2.68)

Screening process

CBE followed by BUS or MAM

4

1,303,128

679

0.48 (0.40–0.56)

BUS followed by MAM

22

11,278,524

9,223

0.94 (0.70–1.20)

BUS in parallel with MAM

12

172,882

501

3.29 (2.48–4.21)

Screening time

Before2012

18

2,325,418

1,468

1.38 (1.08–1.71)

In and after2012

21

10,433,286

8,940

1.26 (0.96–1.60)

Follow-up method

No

16

8,049,956

6485

0.81 (0.51–1.17)

Interview

13

4,633,43

3,726

1.41 (1.15–1.69)

Second screening

10

75,311

197

2.54 (1.65–3.61)

  1. Abbreviations: CDRs cancer detection rates, it was calculated as the number of detected breast cancers divided by the number of participants